Form 8-K - Current report:
SEC Accession No. 0001213900-23-058324
Filing Date
2023-07-20
Accepted
2023-07-20 08:30:10
Documents
14
Period of Report
2023-07-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea182024-8k_longeveron.htm   iXBRL 8-K 28246
2 PRESS RELEASE DATED JULY 20, 2023 ea182024ex99-1_longeveron.htm EX-99.1 12104
6 GRAPHIC ex99-1_001.jpg GRAPHIC 11066
  Complete submission text file 0001213900-23-058324.txt   236943

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE lgvn-20230720.xsd EX-101.SCH 3021
4 XBRL LABEL FILE lgvn-20230720_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE lgvn-20230720_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT ea182024-8k_longeveron_htm.xml XML 3410
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 231098151
SIC: 2834 Pharmaceutical Preparations